Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
First, let me apologize, as I sometimes forget that my impeccable track record of being correct can cause great concern when I post things others don’t want to hear.
I now also realize, that even when I say “a feeling,” “could be wrong,” or “assumption” that most believe the statement which follows will come true, because it always does.
So let me reply point by point, then I have things to get back to:
“Trying to lower the value of the stock”
…. If this were true I would be saying -sell now before it hits 0.06. No, I am suggesting $2-3.50. That’s a massive 1275% return on investment at today’s market value. So I am actually being very positive.
“What test result were those Wave?”
…now, though many think my uncanny knowledge of UHP, Hemostyp and PMA guidelines means I must be connected somehow, it’s simply not the case.
Therefore, clearly I am speaking of past results. The current tests are still under way according to UHP documentation. So if you believe company officials then clearly I can’t know these results. I emphasized this by stating that ….UHP “testing has returned unsatisfactory results which they essentially admitted.” I thought these results were made clear to all in previous PRs. Which they were.
UHP stated “ with the laboratory leadership, believes resulted from unintended partial oxidation during the sample cutting and packaging process that was conducted by an external component supplier. ” for further info please see Appendix A.
Hopefully everyone can keep up, I know this is long. But I was called out, so it’s necessary.
Next : “ The other thing that made ZERO sense”
When one introduces a statement with “Just for weekendBBQ UEEC talking points. Hot take predictions: ” it should be assumed that these are Just for weekendBBQ UEEC talking points. Hot take predictions: hears what hot take means-“ a piece of commentary, typically produced quickly in response to a recent event, whose primary purpose is to attract attention.” So that was made clear in my intro. to the predictions.
In conclusion $2-3.50 is a glorious return and even if it is not what you want, in no way is a prediction of this size going to lower the price.
Yours truly,
Wavy.
PS. Please excuse any grammar or spelling errors (doubt it) as I don’t have time to review.
Also, someone with my track record of success and accuracy should never have to explain to this degree.
Appendix A:
Manufacturing and Packaging of our Products
The Company’s NORC products will be manufactured to our specifications and using our equipment through a contract manufacturing arrangement with an FDA certified supplier that maintains stringent quality control protocols to assure the uniformity and quality of all of our gauze products. Information on the manufacturing process and our manufacturer’s facility has been submitted as part of our PMA submission. Our gauze products are cut to size, packaged and sterilized by service providers in the United States.
I have a feeling we will soon learn that UHP has abandoned their quest to produce Hemostyp in the USA. Hence, the emphasis that now the Cutting and packaging is happening in a USA plant, not the manufacturing.
Could be wrong (doubtful) but Either way, using two facilities seems like a logistical nightmare for a company like UHP and it is my assumption that this is a huge part of why the testing has returned unsatisfactory results which they essentially admitted.
These changes wreak havoc on the original PMA and were the reasons I stated repeatedly that major amendments were needed.
Just for weekendBBQ UEEC talking points. Hot take predictions:
$2-3.50 With PMA
12+ months to PMA decision
24 months to acquisition.
In the mean time UHP May be presented a low ball offer of approximately $0.48.
This excludes potential pump and dumps.
Have a tremendous weekend. And RELAX a little.
Then you would agree, no one on here has any clue what Beplate’s “liquid cash flow” is.
Therefore, you also have no clue what offer he’d be willing to accept.
You have said that Beplate has “never sold a single share.” This is false. He has sold shares as low as $0.07 in the past.
Plus, He has been accused and found guilty of deliberately misleading shareholders.
That’s us….be lied and deceived us, so I wouldn’t put him on a pedestal without knowing his history.
There is a common theme amongst “longs” that Beplate would never sell below some random $pps that has been created by aggressive posters.
I’m ecstatic with any offer $3 or more and fully understand this may be out of reach. If Shareholders sign off on a $2 offer I fully accept that and will take my profits and run.
$2 is 10 times todays value, so please don’t accuse me of trying to drive the price down.
Have at it friends, looking forward to replying to your respectful posts tomorrow.
Curious that Thom would try to sell 300,000 shares at this point.
Assuming that he has actually been contacted by interested partners (as his Filings and PRs state) and that he is truly an Acquisition expert, why would he do this.
Especially, if he has any inkling that his shares could be worth over $2 - $10 per share after the “bidding war.”
Even if he’s completely out of money (which he shouldn’t be considering his past success and that he has two other jobs at this time)
I have been told I’d be smoking something if I sell at $3.10 yet our CEO acquisition expert is willing to sell at $0.25.
I’m not a market expert so would love if someone with expertise could politely offer a REALISTIC explanation for this.
I’m not questioning the product. Potential.
Again, why sell 300,000 now if they could be worth over $1M within 3 years?
What does this say about his insight into future share value?
Clearly I was using “even $1” as an example that while Thom has much to gain as long as he finds a acquiring partner, many here can still lose.
Also, if I asked you in 2018 if we would still be sitting here without a PMA and the stock at $0.20 FIVE years later you’d have called me every name in the book.
Yet, here we are. None of us would have predicted this debacle. Therefore, we certainly don’t know what shareholders would agree to in 1,2,3,4, 5 more years. That’s just crazy talk right.
Personally (meaning, my stance) I’d take my $3.10 today. However, I’m not sure how many years it will take to get there, but I’ll wait.
My Original quote: May 9th 2019.
“Meaning an aquiring Company could purchase at about $3.10. “
What is all this talk about -what he is allowed to share within the rules and regulations? Another, common line on this board.
He has nothing to share as there is nothing new to share. He refers all questions to upcoming PRs.
Also, you have no idea if the UHP executives have more to lose than most everyone here.
For all you know someone may be foreclosing on a house or not able to send a kid to college as the money tied up here is worth 1/6 if it’s value when Thom took over.
Losses are relative. A poster here has claimed to hold over 800,000 shares.
He is now sitting on a market value loss of $800,000 compared to when Thom took over.
When Thom finds a buyer for this company for even $1 per share he makes $11,000,000. Guaranteed.
While others here may lose thousands.
Do your homework.
The CEO and his team have NOT done everything possible to make this happen and maximize shareholder value, as I have outlined many times.
Being intelligent isn’t angry. It’s simply exposes what needs to be said.
Shoving your head in the sand and ignoring reality isn’t happy, its delusional.
Im out!! Long and capable of intelligent debate….and happy.
.
If it’s been a concern for 5+ years, that doesn’t make the info less valuable, but More valuable.
Perhaps 5 years ago when Human Trials were underway, or 3 years ago when PMA was starting the submission process and most here thought Approval was “imminent “, the fact that this company was running on fumes seemed manageable.
But, after 5 plus years and literally no end in sight to the PMA process, the desperation grows.
We’re past the point of cliché “PAYtience always pays” and “buying opportunities “
If this can’t get sorted out they WILL end up in a buyout situation that is Not acceptable to anyone here based on where this stock was (BTW, 5 years ago. $0.90…)
But I suppose that doesn’t matter. It’s all just “garbage”
Another statement in every 10k, 8k, most PRs for 5 plus years is that they’ve been contacted by potential partners and negotiations are underway…..
First test was rush and deemed not extensive enough.
Second test rushed and deemed unsuccessful.
Third test underway and not being rushed.
This is why these test should have been done 2 yrs ago when they claimed to have contracted a USA manufacturing co.
In fact, these tests should have been run before claiming to have left China.
This needs to get done properly once and for all. TIME IS TRULY RUNNING OUT!
Of note from 10k.
“Our independent registered public accounting firm has expressed substantial doubt about our ability to continue as a going concern. This could make it more difficult for us to raise funds and adversely affect our relationships with creditors, investors and suppliers.
Our auditors believe that substantial doubt exists regarding our ability to remain in business. We cannot provide any assurance that we will in fact operate our business profitably or obtain sufficient financing to sustain our business in the event we are not successful in our efforts to generate sufficient revenue and operating cash flow. The expression of such doubt by our independent registered public accounting firm or our inability to overcome the factors leading to such doubt could have a material adverse effect on our relationships with prospective customers, creditors, investors and suppliers, and therefore could have a material adverse effect on our business.“
“ Let him move in silence but effectiveness..”
This isn’t a spy movie. The Equalizer isn’t coming to save the day. This is a public company.
Plus, this company pumps every bit of good news they get. So Thom’s not silent when there’s positive info (which is infrequent and often misleading)
He is certainly not Moving in “effectiveness “.
Unless, taking a Mustang that just needed a little tune up and turning it into a broken down lemon that needs a complete rebuild is effectiveness.
Well, at least that would get us to the 0.60s. I’d prefer the $1.20s where it was before Thom and his “solid team”came aboard and sunk it.
Congratulations to Thom.
He just received another 309,000 shares.
“Common Shares were issued by the Issuer to the Reporting Person pursuant to Rule 16b-3(d)(1) in payment of salary in lieu of cash payment.”
Even at these brutal prices that’s $68,000.
Remember, when Thom took over those same shares would have been worth $370,000.
So if he can just get UEEC back to where it was before he came in and destroyed it, he wins again.
You can’t teach this stuff.
So because the pps stayed within range of the past few months (which clearly it isn’t anymore) everything is cool?
Even though the range of the last few months was the lowest in 5 YEARS!
Not setting the bar to high there are you.
That’s like telling your Child who was a A+ student as a Freshman but fell to a D- as a Senior due to lazy mistakes…” that’s OK son, because you were a D student last semester as well. Who cares if you now have limited opportunities “
As Hemostyp creeps towards the finish line you want the pps to be going up not down (or equal to its worst Q in 5 years)
Whether this is a binary event or not, the higher the pps the better for maximizing value.
No matter how “positive “ you want to sound, every delay, mistake and missed opportunity causes further dilution, loans, payments via shares. That is not good for shareholder value.
Sorry for slow reply. I’m only allowed one post a day so won’t be checking in too often.
They’ve had a consultant for a long time.
Somehow he didn’t know that all of this testing had to be done in order for the PMA to progress.
If I knew- please tell me they knew.
If they truly have full access to the consultant and he didn’t advise UHP immediately upon being contracted -and learning that UHP moved factories after human trials.- that they MUST produce USA product, then yes the consultant is “that stupid to make mistakes like this.”
Second inconsistent messaging:
Originally RCA advised that if first test is successful , then within a FEW days the PMA would move forward.
Apparently Test was a success! But then new Test is ordered- why?
They never mentioned this before.
Shouldn’t experts have known this would be needed and if they did why did they say “a few days” originally???
Reason - they screwed up the test process.
Then when they do a complete test the true results come in.
You will know the true level of incompetence when we are still wondering what stage of the process we’re in as we enter 2024!
I ASSURE you.
I can and I did.
My track record of unbiased posts gives me that ability.
I can assure you the additional batches were not produced as insurance etc.
Rather, the first batch wasn’t produced and packaged for transport.
Meaning, the first batch was not a proper test to compare head to head with the product used in trials. Yet another corner cutting error by the consultant and Thom.
I feel you had it right before when you stated: “ I don't believe anything they say Dark. Learned my lesson a long time ago. If you took the amount of crap they told people that didn't come true, you would have a dinosaur pile of crap about 10 feet wide and 7 feet high.”
The human trials are void unless they can get this USA Hemostyp identical to the China Hemostyp used in trials.
The 180 day clock is the least of our worries at this point.
370 days ago and counting:
March 24 2022 -( if I knew, they knew)
“ As I mentioned before, all delays are manufacturing related.
There is nothing the FDA can do until UHP can prove capable of producing hemostyp gauze in the new facility exactly as they used in the human trials.
As a result, until they get a line running at Strouse (or wherever they intend to make it now) the FDA can not complete the approval.”
Payday for Thom on Friday—- another $15,000. Bringing his total to approximately $375,000.
Don’t forget decades:
This is when I started following ueec. It was exciting times.
United Health Products Receives Notice of Allowance for Patent
From Aug 2013 to Sep 2013
United Health Products, Inc. (OTCQB: UEEC) announced that it has received formal notification of allowance of its patent application from the U.S. Patent Office for its hemostatic gauze product, HemoStyp™, and that the patent will issue shortly. The Company is also pursuing additional applications and filings for its HemoStyp product line.
HemoStyp is an all-natural product comprised of regenerated oxidized cellulose gauze which is specifically formulated to aid in the process of hemostasis (clotting) when positioned on a cut or wound. Unlike the other products in the wound care market, HemoStyp contains no potentially harmful chemicals or animal byproducts and is hypoallergenic. Once it has completed its task, it is easily removed by dissolving it in water or saline solution. This method of removal neither disturbs the clotted surface nor encourages re-bleeding.
Dr. Phillip Forman, CEO of United Health Products, stated that, "Now that the Company has obtained full patent rights for HemoStyp, we look forward to entering the next phase of sales and marketing with our patented product."
The Company expects its first orders from the dental and medical markets as it is now pursuing multiple markets for HemoStyp including the medical, sports, dental, military, and veterinary sectors, each of which represents a multimillion dollar market.
About United Health Products, Inc.
United Health Products, Inc. (UEEC) develops, manufactures, and markets a patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp™, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products, Inc. visit: www.unitedhealthproductsinc.com.
Safe Harbor Statement
The CTQ program and Hemostyp’s participation ended in Dec 2018.
It is not an ongoing program.
Many used to refer to this as a “fast track” program.
It was not.
What’s a PMA CTQ?
As a follow up to my deep concern for DP’s finances….:
“Sarcasm is lost on many people, in some cases more than others, because they may be missing part of a complex set of cognitive skills based in specific parts of the brain.”
He committed fraud and knew his days were numbered:
SEC June 2022
“5. As a result of Beplate's and Schiliro's fraud, UHP reported materially overstated total revenues and accounts receivable balances in its Forms 10-Q and 10-K for 2017 and 2018, each of which Beplate signed and falsely certified.”
Plus, he held one of the all time worst conference calls. :/
Yes, the mismanagement has been rampant for many many years.
Just think about how Beplate must feel.
He’s down $30 Million since he appointed this “solid team” of part time employees.
I suppose this Solid Team has potential to hit both ends of a binary event:
“ When investors and traders hear the term “binary event,” they usually think of biotechnology companies that explode higher after FDA approval, or of a company that had its stock cut in half (or worse) due to mismanagement. ”
They’ve already achieved the latter with flying colors.
The former was handed to them on a silver platter but they seem unable to nail that one down.
Good news for strong team.
Just one more week………,,
Until Thom and “strong team” cash another hard earned check..
Another $15,000 for our leader. I wonder what extra part time work he did to earn it.
Hopefully, more than June 2022 when he prepared (ha ha) for the July FDA meeting.
What is a pr for a CTQ enrolment notice?
The move began Q4 2019 and was completely voluntary, without input from FDA. As we learned in 2022, they may have moved out in 2019/20 but didn’t really move IN to new facility until 2022.
So, other then the Uhaul PO Box the manufacturing was essentially homeless for 2 yrs.
Not smart when your PMA is already submitted based on China’s product.
The reasoning for the move was provided many times…IE:
Dec 2019
Commenced the process of relocating the majority of its manufacturing to a United States facility. Once fully operational, the facility will be capable of manufacturing up to 20 million square inches of HemoStyp gauze monthly. Additional formulations of the HemoStyp product designed for the specialized human surgical market will also be produced at this facility. UHP is onshoring its production operations to improve its order response time, reduce freight costs and improve scalability.
What’s your criteria for a Solid team?
A simple Ihub poster was able to forecast exactly what the FDA required before approval. Yet, their solid team failed to step up and submit a complete PMA. —— repeatedly.
For 4 years I have heard this product described as A market changer, sure thing success. Capable of dominating the Billion $ market upon approval. Yet here we are.
Previous solid team stumbled so a new Team stepped in.
This team has done just enough to earn a paycheque. Always sure to pump a PR when there is something hinting at success in the pipeline, only to announce further delays later on.
Share price under solid team down 85%.
Solid teams are proactive not reactive.
Solid teams work tirelessly to complete a PMA correctly the first time.
Solid teams don’t speak in vague terms.
Two possibilities:
The poor guys gotta eat.
Or, he purposely took the 2022 loss from when he originally acquired them.
He knew he had another batch of 225,000 coming his way on January 13th.
Your link includes approved Supplements to PMA devices.
About 95% of FDA approval work is on PMA supplements. Every change to a PMA device and it’s manufacturing process must be approved.
Here’s the definition of theory from google. So yes it’s a theory. Likely 100% accurate, but still just a theory.
Theory Definition and unbelievably appropriate example from the good old internet:
“”an idea used to account for a situation or justify a course of action.
"my theory would be that the place has been seriously mismanaged"”
I’m not building a case, I’m stating the facts of his contract and aligning them with a lack of accountability. The two work hand in hand.
Somehow, Others see his ridiculous contract and lack of results as a “positive “
I try to let it pass, but my common sense won’t allow it.
Sure did. People in any position are not obliged to quit their job just because they do it poorly.
“Hi SEC, I’m a poster on Ihub and have personally concocted a theory that my CEO sucks at his job and is way over paid. Please open an investigation immediately “…..
5 mins later:
“Dear Mr. Waverunner we’ve completed our fast track investigation and it appears other posters are happy with the CEO and some are down right giddy, so we’re not sure if he should quit or be given a raise. “
“In conclusion, you are an Ihub poster Mr Waverunner (if that’s really your name). Never contact us again and tell Scumbag to lighten up.
What are you talking about. I never said one word about falsifying information.
Does everyone on this board read things and just create their own reality out of it.
Being incompetent is not falsifying information.
On the other hand AlwaysIntheknow did say they have submitted past PMAs to just give it a go. And he felt that was acceptable.
This is of course not what anyone thinks:
“ however for anyone that thinks just stringing this along for a bit more money as opposed to gaining approval for the big enchilada is a real strategy, I can't help you.”
Instead, my comments have eluded to the Fact that he is incompetent and his worst case scenario is that he gets fired and his 11.5 million RSUs become vested. Then when his advisors finally get this done right, he can cash out.
In the mean time he may as well just continue to “give it a go” (as you put it)
And if he is repeatedly sent back to re do the PMA there is no damage to his finances… he continues to collect 15,000 a month and some day will walk away with 22million +++ .
Oberon takes their 50% the Government takes theirs and he’ll still have $5 million+++. So while your investment is currently worth 25% of what it was when he took over, his balance goes up up up.
That’s just painfully boring.
So in other words he did some portions of his job. Yay.
Hence, he can’t be fired for incompetence.
He’s doing just enough to get by.
You nailed it Trust.
Sadly, his contract is so rich I don’t think UHP can fire him.
Good work by his employer Oberon in negotiating that contract for him.
——/
Principal
Waveny Partners, LLC
Jun 2019 - Present3 years 8 months
Greater New York City Area
Oberon Securities, LLC Graphic
Managing Director
Oberon Securities, LLC
Aug 2019 - Present3 years 6 months
New York City Metropolitan Area
Societe Generale Americas Graphic
Managing Director - Head of Americas Corporate Finance
Societe Generale Americas
Jun 2014 - Jun 20195 years 1 month
United States
Everyone knows we are tracking towards eventual approval. I have said that many many times.
Is that positive enough for you.
Did you see my thumbs up.
Yahoooo!
Are you aware that in addition to the $180,000 per yr. Thom makes with this part time job, that his 11.5 million RSUs become vested if he is terminated without UHP proving probable cause.
Unfortunately being incredibly incompetent is not sufficient cause in this case.
So though I once posted that his quickest route to riches was finding a buyer. It could be argued that windfall would come quicker by being Fired.
Old incomplete PMAs mean nothing to the current timeline. Their attempt to Just “give it a go” was a waste of time. The FDA will implement the UP TO 180 DAYS once this is completed and not a second before:
“The company will now incorporate these laboratory results and other data into its PMA application for submission as soon as possible. Concurrently with these final steps for completion of its application, UHP continues to engage with the FDA on various technical aspects of its review process.”
Since they clearly didn’t submit “after a few days “as previously promised, and they have now added the vague -“ UHP continues to engage with the FDA on various technical aspects of its review process.”
They have allowed for an unlimited array of excuses to drag out the final submission.
Once it is accepted as complete I believe the FDA will start its (up to) 180 day review.
At this point they owe UHP NO favors.
Especially after wasting FDA and Shareholder time and resources just “giving it a go”
I’ll give you a tip on how to know when your predictions will be wrong….:
>>When they don’t align with my FACTS.
——-
Is that “black and white” enough for you.
Or Will you need to “read between the lines” some more.
There is no “grey” in that statement.
There is no need for predictions based on someone else’s actions.
I have no control of how they write their PMA and when they submit it.
I only know the standards the FDA expects and the timelines they work within.
A prediction by me or anyone else is meaningless.
When the 100% complete PMA is submitted, we will have an answer within 180 days. That’s a FACT not a prediction.